pentylenetetrazole has been researched along with vorinostat in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de la Hoz, CL; Gavrilovici, C; Ibhazehiebo, K; Kaushik, G; Kim, DY; Kurrasch, DM; Ma, SC; Meza Santoscoy, PL; Nath, N; Rehak, R; Rho, JM; Scott, L | 1 |
1 other study(ies) available for pentylenetetrazole and vorinostat
Article | Year |
---|---|
A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target.
Topics: Animals; Animals, Genetically Modified; Anticonvulsants; Disease Models, Animal; Drug Delivery Systems; Drug Evaluation, Preclinical; Electroshock; Embryo, Nonmammalian; Energy Metabolism; Histone Deacetylase Inhibitors; Histone Deacetylases; Kv1.1 Potassium Channel; Mice; Morpholinos; Pentylenetetrazole; Psychomotor Performance; Seizures; Vorinostat; Zebrafish | 2018 |